Eli Lilly announces a temporary shortage of Humalog and Insulin Lispro Injection until April due to high demand and manufacturing delay.
Eli Lilly announces a temporary shortage of two insulin products, Humalog and Insulin Lispro Injection, in 10mL vials, due to high demand and a brief manufacturing delay. The shortage is expected to last until the beginning of April, and patients may need to consult their doctors for alternative insulin treatments. Eli Lilly offers a $35 coupon program for uninsured customers.
March 25, 2024
5 Articles